Physician profile

Marley Jackson

Nurse Practitioner · Saint Peters, MO

NPI 1730079310

$204.86

in general payments reported to CMS, 2019-2025

2 companies · $205 in 2025

The $205 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$204.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Neurocrine Biosciences, INC. $117.95 2025
Pfizer INC. $86.91 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Marley Jackson

$204.86

in general payments reported 2019-2025

Years
2025
Top company
Neurocrine Biosciences, INC.
Context
The $205 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).

https://glasscript.com/doctor/11844978/marley-jackson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.